The Belgian government finalizes an agreement to buy 20,000 courses of Pfizer's Paxlovid COVID-19 drug and Merck & Co.'s Molnupiravir COVID-19 drug. (The Brussels Times) COVID-19 pandemic in Belgium, COVID-19 drug developmentCOVID-19 pandemic in EuropeCOVID-19 pandemic link embed save